Semnur Pharmaceuticals (SMNR) Cash from Financing Activities (2022 - 2026)
Semnur Pharmaceuticals (SMNR) reported Cash from Financing Activities of $2.07 million for Q2 2026, compared with -$220,000 a year earlier and down 24.7% from the prior quarter.
Powered by 
Analysis
Semnur Pharmaceuticals (SMNR) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Semnur Pharmaceuticals' Cash from Financing Activities came in at $10.53 million, up 120.3% year-over-year; for FY2025, it came in at $5.88 million, up 20.1% from FY2024.
- Cash from Financing Activities has a three-year compound annual growth rate of -59.0% (FY2022 to FY2025).
- By year, Cash from Financing Activities came in at $4.89 million in FY2024, -$39.69 million in FY2023 and $85.4 million in FY2022.
- Five-year quarterly Cash from Financing Activities spans a low of -$40.19 million in Q4 2023 and a high of $85.46 million in Q2 2022.
- Year over year, Cash from Financing Activities gained in three of the last four quarters, with growth averaging 212.2%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.75 million (Q1 2026), $3.54 million (Q4 2025) and $2.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Semnur Pharmaceuticals | 65.31 Mn | 65.10 Mn | - | 2.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.24 Mn |
| Jun 30, 2026 | 2.07 Mn |
| Mar 31, 2026 | 2.75 Mn |
| Mar 31, 2025 | 394,000.00 |
| Mar 31, 2024 | 170,700.00 |
| Dec 31, 2023 | -40.19 Mn |
| Sep 30, 2023 | 80,000.00 |
| Jun 30, 2023 | 412,500.00 |
| Sep 30, 2022 | -81,500.00 |
| Jun 30, 2022 | 85.46 Mn |
| Mar 31, 2022 | 16,567.00 |
API Access
Semnur Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SMNR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "SMNR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SMNR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();